Ruben Vageevich Oganesyan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 5 | 2021 | 1394 | 0.680 |
Why?
|
| Mammaplasty | 1 | 2022 | 1232 | 0.410 |
Why?
|
| Hip Prosthesis | 3 | 2020 | 921 | 0.340 |
Why?
|
| Arthroplasty, Replacement, Hip | 4 | 2021 | 1413 | 0.340 |
Why?
|
| Tissue Scaffolds | 3 | 2024 | 932 | 0.270 |
Why?
|
| Prosthesis-Related Infections | 2 | 2021 | 488 | 0.240 |
Why?
|
| Reoperation | 5 | 2021 | 4303 | 0.240 |
Why?
|
| Osteitis Deformans | 1 | 2022 | 54 | 0.200 |
Why?
|
| Elastin | 1 | 2022 | 298 | 0.190 |
Why?
|
| Extracellular Matrix | 3 | 2024 | 1720 | 0.190 |
Why?
|
| Nipples | 1 | 2022 | 229 | 0.180 |
Why?
|
| Posterior Cruciate Ligament | 1 | 2020 | 85 | 0.170 |
Why?
|
| Knee Joint | 4 | 2021 | 1678 | 0.170 |
Why?
|
| Glycosaminoglycans | 1 | 2022 | 607 | 0.170 |
Why?
|
| Hepatocytes | 2 | 2024 | 1231 | 0.170 |
Why?
|
| Fatty Liver | 1 | 2024 | 789 | 0.140 |
Why?
|
| Knee Prosthesis | 1 | 2020 | 395 | 0.140 |
Why?
|
| Hip Dislocation | 1 | 2020 | 248 | 0.140 |
Why?
|
| Arthritis, Infectious | 1 | 2020 | 347 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 20982 | 0.120 |
Why?
|
| Polyethylene | 3 | 2020 | 185 | 0.120 |
Why?
|
| Mastectomy | 1 | 2022 | 1818 | 0.120 |
Why?
|
| Collagen | 1 | 2022 | 2635 | 0.120 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1865 | 0.110 |
Why?
|
| Arthroscopy | 1 | 2021 | 969 | 0.110 |
Why?
|
| Swine | 1 | 2022 | 5909 | 0.100 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 1852 | 0.100 |
Why?
|
| Liver | 2 | 2024 | 7514 | 0.090 |
Why?
|
| Corrosion | 2 | 2020 | 26 | 0.090 |
Why?
|
| Prosthesis Failure | 3 | 2020 | 1204 | 0.090 |
Why?
|
| Osteoarthritis, Knee | 1 | 2020 | 1236 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2022 | 80674 | 0.080 |
Why?
|
| Prosthesis Design | 3 | 2020 | 2114 | 0.080 |
Why?
|
| DNA | 1 | 2022 | 7189 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2020 | 3821 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11509 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2022 | 6341 | 0.060 |
Why?
|
| Range of Motion, Articular | 2 | 2020 | 1590 | 0.060 |
Why?
|
| Tissue Donors | 2 | 2024 | 2335 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 41496 | 0.050 |
Why?
|
| Cobalt | 1 | 2020 | 148 | 0.040 |
Why?
|
| Blood Sedimentation | 1 | 2020 | 235 | 0.040 |
Why?
|
| Humans | 13 | 2024 | 761208 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2020 | 393 | 0.040 |
Why?
|
| Debridement | 1 | 2020 | 493 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2022 | 612 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2021 | 64681 | 0.040 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2020 | 423 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 168079 | 0.030 |
Why?
|
| Gait | 1 | 2020 | 810 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1916 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7407 | 0.020 |
Why?
|
| Recurrence | 1 | 2021 | 8457 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2024 | 18926 | 0.020 |
Why?
|
| Age Factors | 1 | 2024 | 18384 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6417 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2021 | 3265 | 0.020 |
Why?
|
| Female | 2 | 2022 | 392544 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2021 | 9319 | 0.020 |
Why?
|
| Prevalence | 1 | 2022 | 15721 | 0.020 |
Why?
|
| Rats | 1 | 2021 | 23704 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 26199 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 36169 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20588 | 0.010 |
Why?
|
| Aged | 2 | 2022 | 169288 | 0.010 |
Why?
|
| Middle Aged | 2 | 2024 | 220853 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36415 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 221119 | 0.010 |
Why?
|
| Male | 1 | 2021 | 360693 | 0.000 |
Why?
|